IRVINE, Calif.--(BUSINESS WIRE)--Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, announced today that an overview of the Company’s business strategy will be given at the Citi Investment Research 2011 Global Health Care Investor Conference, being held in at the Hilton New York Hotel in New York City, New York. The Spectrum Pharmaceuticals presentation is at 8:30a.m. Eastern Time on Wednesday, March 2, 2011.
